Rinvoq ER 15 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FP3QB
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,848
Award facts
- Contract value 100% obligated
- $25,848.42 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp valued at $25,848.42 for RINVOQ ER 15 mg tablets (30-count unit of use packaging) on September 24, 2025, with completion scheduled for September 25, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. RINVOQ (upadacitinib) is a JAK inhibitor used in the treatment of rheumatoid arthritis and other inflammatory conditions, reflecting the pharmaceutical procurement needs of the Department of Defense medical supply chain.
This delivery order is executed under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which holds a $999.9 million ceiling through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen Drug Corp leverages this comprehensive global contract vehicle to supply a wide range of pharmaceutical products and medical commodities to support military healthcare programs worldwide. The company's award demonstrates its continued capability to meet competitive federal procurement requirements and serve Defense Health Agency and other government healthcare systems with specialized medications and medical supplies.
Quick answers
Who was awarded contract SPE2DB25FP3QB?
SPE2DB25FP3QB was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 24, 2025.
How much is contract SPE2DB25FP3QB worth?
The government has obligated $25,848 on SPE2DB25FP3QB.
Is contract SPE2DB25FP3QB an order under another contract?
Yes. SPE2DB25FP3QB is a delivery order under SPE2DB22D3010, an indefinite delivery contract.
Was contract SPE2DB25FP3QB competed?
The extent of competition for SPE2DB25FP3QB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award